Evaluation of Drug Use Practices Using WHO Core Drug Use Indicators at Pediatric Health Facilities, Kabul, Afghanistan




Core Drug Use Indicators
Drug use patterns


How to Cite

Habibyar AF, Hamid H, Zahier NA, Nazari QA, Sharma N, Khurana N. Evaluation of Drug Use Practices Using WHO Core Drug Use Indicators at Pediatric Health Facilities, Kabul, Afghanistan. Integr J Med Sci [Internet]. 2021 Jul. 13 [cited 2024 Jun. 15];8. Available from: https://mbmj.org/index.php/ijms/article/view/479


Background: Irrational medicine use is a global problem. It can lead to increased morbidity and mortality and increased costs of drug therapy, thus imposing an adverse impact on the overall quality of the pharmaceutical care system. Objective: To evaluate drug use practices based on WHO core drug use indicators at pediatric health facilities of Kabul, Afghanistan.
Methods: A cross-sectional study was conducted at outpatient departments of the three pediatric health facilities at samples that were collected using a systematic random sampling method. The sample size included 600 outpatient prescriptions. Data were evaluated as per the WHO guidelines.
Results: On average 2.795, 2.745, and 4.2 drugs per prescription were prescribed in 001, 002, and 003 health facilities respectively (WHO standard is 1.6-1.8). 37.03% of drugs in 001, 42.62% in 002, and 42.64% of drugs in 003 were prescribed by the generic name (WHO standard is 100%). Antibiotics were prescribed in 79% prescriptions of the 001, 88% of the 002, and 52% of the 003 health facilities (WHO standard value is 20-26.8%). Injections were prescribed in 6% of the 001, 32% of the 002, and 19.5% of the 003 prescriptions (WHO standard is 13.4-24.1%). 65.47% of drugs in 001, 67.94% of drugs in 002, and 73.1% of drugs in 003 health facilities were prescribed from the Afghanistan national essential medicines list (WHO standard is 100%).
Conclusion: Most of the core drug use indicators were not met with WHO standards in these pediatric health facilities. However, in 001 and 003 health facilities the prescribing patterns may be more complex because they are tertiary health care centers.



Management science for health. MDS-3: Managing access to medicines and health technologies. USA: Kumarian Press; 2012. pp.1.6, 3.6, 27.12. [Accessed 2021 Jun 9]. Available From : https://www.msh.org/sites/default/files/mds3-jan2014.pdf

World Health Organization. How to investigate drug use in health facilities: selected drug use indicators. Geneva: World Health Organization (EDM research series no. 007); 1993. Chapter 2, Core drug use indicators. [Accessed 2021 Jun 9]. Available From: https://apps.who.int/iris/bitstream/handle/10665/60519/WHO_DAP_93.1.pdf?sequence=1&isAllowed=y

Sisay M, Abdela J, Kano Z, Araya M. Drug Prescribing and Dispensing Practices in Tertiary Care Hospital of Eastern Ethiopia: Evaluation with World Health Organization Core Prescribing and Patient Care Indicators. J Clin Exp Pharmacol. 2017 May; 7(3):1-8. http://dx.doi.org/10.4172/2161-1459.1000238

Mohajer KA, Al-Yami SM, Al-Jeraisy MI, Abolfotouh MA. Antibiotic prescribing in a pediatric emergency setting in central Saudi Arabia. Saudi Med J. 2011 Feb; 32 (2):197–8. [Accessed 2021 Jun 9]. Available From: https://smj.org.sa/content/smj/32/2/197.full.pdf

Al-Niemat SI, Aljbouri TM, Goussous LS, Efaishat RA, Salah RK. Antibiotic prescribing patterns in outpatient emergency clinics at Queen Rania Al Abdullah II Children's Hospital, Jordan, 2013. Oman Med J. 2014 Jul; 29(4):250–4. https://doi.org/10.5001/omj.2014.67

Ahmed AM, Awad AI. Drug use practices at pediatric hospitals of Khartoum State, Sudan. Ann Pharmacother. 2010 Dec; 44(12):1986–93. https://doi.org/10.1345/aph.1p423

Fadare JO, Olatunya O, Oluwayemi OI, Ogundare OE. Drug prescribing pattern for under-fives in a paediatric clinic in South-Western Nigeria. Ethiop J Health Sci. 2015 Feb; 25(1):73–8. http://dx.doi.org/10.4314/ejhs.v25i1.10

Akhtar MS, Vohora D, Pillai KK, et al. Drug prescribing practices in pediatric department of a North Indian university teaching hospital. Asian J Pharmand Clin Res. 2012 Mar; 5:146–9.

World Health Organization (WHO). Introduction to Drug Utilization Research. Oslo, Norway: WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services; 2003; p.16. [Accessed 2021 Jun 9]. Available From: https://apps.who.int/iris/bitstream/handle/10665/42627/924156234X.pdf?sequence=1&isAllowed=

Cole CP, James PB, Kargbo AT. An evaluation of the prescribing patterns for under five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Clin Pharm. 2015 Sep; 6(4):109-14. https://doi.org/10.4103/0976-0105.168051

World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. Geneva. 2015.

Kumar SG, Adithan C, Harish BN, Sujatha S, Boy G, Malini A. Antimicrobial resistance in India: a review. J Nat Sci Biol Med. 2013 Jul; 4(2):286–91. https://doi.org/10.4103/0976-9668.116970

Sharif IS, Nassar AH, Al-Hamami FK, Hassanein MM. Trends of pediatric outpatients prescribing in Umm Al Quwain, United Arab Emirates. Pharmacol pharm. 2015 Jan; 6(1):9–16. http://dx.doi.org/10.4236/pp.2015.61002

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2021 Ahmad Farid Habibyar et al.


Download data is not yet available.


Metrics Loading ...